May 7 (SeeNews) - Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNL] said it recorded a net profit of 5.6 million marka ($3.3 million/2.9 million euro) in the first three months of 2025, reversing a net loss of 4.9 million euro in the same period last year.